Approvals/TGA/JANUMET 50 mg/850 mg sitagliptin phosphate monohydrate/metformin HCI 50 mg/850 mg tablet blister pack

Approved

STANDARD

JANUMET 50 mg/850 mg sitagliptin phosphate monohydrate/metformin HCI 50 mg/850 mg tablet blister pack

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: deb221352d5db7a9
Product Name: JANUMET 50 mg/850 mg sitagliptin phosphate monohydrate/metformin HCI 50 mg/850 mg tablet blister pack
Artg Id: 149021
Artg Name: JANUMET 50 mg/850 mg sitagliptin phosphate monohydrate/metformin HCI 50 mg/850 mg tablet blister pack
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2009-04-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/e808d71a577867782ea8badbf7c93a1f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e74b7fd4230d4a537675d20c74998dd0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

deb221352d5db7a9

Type

Standard